EUVIMEDEUVIMED entdecken
Crossref

Chemogenetic astrocyte modulation reduces spontaneous hippocampal discharges and metabolite changes in an epilepsy mouse model

Liam Nestor iD, Yana Van Den Herrewegen iD, Marcus Dyer iD, Jo Bossuyt iD, Evelien Hendrix iD, An Buckinx iD, Sofie Bournons iD, Johan Viaene, Yvan Vander Heyden iD, Mark Van de Casteele iD, Ann Van Eeckhaut iD, Ilse Smolders iD und 1 weitere

Epilepsia · 2025

DOI: 10.1111/epi.18684 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2025. Verfasst von Liam Nestor und 12 weiteren Autor:innen. Beteiligte Einrichtung: Research Group Experimental Pharmacology (EFAR), Center for Neurosciences (C4N), Vrije Universiteit Brussel (VUB), Brussels, Belgium. Hauptthemen laut MEDLINE: Astrocytes, Hippocampus, Epilepsy, Temporal Lobe. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Fonds Wetenschappelijk Onderzoek, Strategic research program of the Vrije Universiteit Brussel, Scientific Fund Willy Gepts of the UZ Brussel.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Temporal lobe epilepsy (TLE) is characterized by recurrent, focal seizures, and up to one third of patients are not adequately treated by the current standard of care. This emphasizes the need for continued research into disease mechanisms and potential novel treatment strategies. In TLE, astrocytes transition to a reactive phenotype and we here investigate how modulation of their activity affects spontaneous seizures.

Methods

We used Gq‐coupled Designer Receptors Exclusively Activated by Designer Drugs (Gq‐DREADD) to target reactive astrocytes in the intrahippocampal kainic acid (IHKA) mouse model for TLE. Through immunohistochemistry, we first verified the astrocyte‐specific expression of Gq‐DREADDs and we quantified astrocytic c‐Fos expression upon Gq‐DREADD activation. Spontaneous inhibitory post‐synaptic currents (sIPSCs) were measured from dentate gyrus granule cells of live hippocampal slices before and after Gq‐DREADD activation. Hippocampal field potentials were monitored in vivo to quantify seizure burden. Finally, metabolic profiling of the hippocampal tissue examined associated effects of Gq‐DREADD activation in epileptic mice.

Results

Gq‐DREADD activation increased c‐Fos expression in astrocytes but not in the neurons of the epileptic hippocampus and rapidly increased sIPSC in hippocampal slices from epileptic mice. We found a significant reduction in the number of spontaneous hippocampal paroxysmal discharges (HPDs) and overall seizure burden 1 day after Gq‐DREADD modulation of reactive astrocytes. The metabolomics analysis at this time point showed 78 metabolites that were significantly altered in epileptic mice, 11 of which were also altered upon Gq‐DREADD modulation of reactive astrocytes, belonging to several metabolic pathways that have been implicated in epilepsy. Significance Our findings provide converging evidence for a modulatory role of reactive astrocytes in TLE. Gq‐DREADD activation of hippocampal astrocytes suppressed HPDs and induced metabolic shifts, offering insight into astrocyte‐driven mechanisms and potential therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AstrocytesHippocampusEpilepsy, Temporal LobeAnimalsMiceDisease Models, AnimalKainic AcidMaleMice, Inbred C57BLMice, TransgenicProto-Oncogene Proteins c-fosChemogenetics

Stichwörter der Autor:innen

DREADDsastrocyteschemogenetic modulationmetabolomicstemporal lobe epilepsy

Substanzen

Kainic AcidProto-Oncogene Proteins c-fos

Autor:innen und Institutionen

  • Research Group Experimental Pharmacology (EFAR), Center for Neurosciences (C4N), Vrije Universiteit Brussel (VUB), Brussels, Belgium.
  • Research Group Analytical Chemistry, Applied Chemometrics and Molecular Modelling (FABI), Vrije Universiteit Brussel (VUB), Brussels, Belgium.
  • Department of Diabetes Pathology and Therapy (DIAB), Vrije Universiteit Brussel (VUB), Brussels, Belgium.

ORCID-Profile: Liam Nestor, Yana Van Den Herrewegen, Marcus Dyer, Jo Bossuyt, Evelien Hendrix, An Buckinx, Sofie Bournons, Yvan Vander Heyden, Mark Van de Casteele, Ann Van Eeckhaut, Ilse Smolders, Dimitri De Bundel

Förderung

  • Fonds Wetenschappelijk Onderzoek
  • Strategic research program of the Vrije Universiteit Brussel
  • Scientific Fund Willy Gepts of the UZ Brussel

Zitieren

APA

Nestor, L., Van Den Herrewegen, Y., Dyer, M., Bossuyt, J., Hendrix, E., Buckinx, A., Bournons, S., Viaene, J., Heyden, Y. V., Van de Casteele, M., Van Eeckhaut, A., Smolders, I., & De Bundel, D. (2025). Chemogenetic astrocyte modulation reduces spontaneous hippocampal discharges and metabolite changes in an epilepsy mouse model. Epilepsia. https://doi.org/10.1111/epi.18684

Vancouver

Nestor L, Van Den Herrewegen Y, Dyer M, Bossuyt J, Hendrix E, Buckinx A, et al. Chemogenetic astrocyte modulation reduces spontaneous hippocampal discharges and metabolite changes in an epilepsy mouse model. Epilepsia. 2025. doi:10.1111/epi.18684

BibTeX
@article{Nestor2025,
  author = {Nestor, Liam and Van Den Herrewegen, Yana and Dyer, Marcus and Bossuyt, Jo and Hendrix, Evelien and Buckinx, An and Bournons, Sofie and Viaene, Johan and Heyden, Yvan Vander and Van de Casteele, Mark and Van Eeckhaut, Ann and Smolders, Ilse and De Bundel, Dimitri},
  title = {Chemogenetic astrocyte modulation reduces spontaneous hippocampal discharges and metabolite changes in an epilepsy mouse model},
  journal = {Epilepsia},
  year = {2025},
  doi = {10.1111/epi.18684}
}
Kostenlos starten →